[Achieving better control of blood sugar--understanding of oral hypoglycemic agents according to their characteristics in pharmacological action mechanism (discussion)]

MeSH terms

• Administration, Oral
• Cardiovascular Diseases / etiology
• Cardiovascular Diseases / prevention & control
• Cyclohexanes
• Diabetes Complications
• Diabetes Mellitus / drug therapy*
• Diabetes Mellitus / physiopathology
• Drug Therapy, Combination
• Glycoside Hydrolase Inhibitors
• Humans
• Hypoglycemia / complications
• Hypoglycemia / drug therapy
• Hypoglycemic Agents / administration & dosage*
• Hypoglycemic Agents / classification
• Hypoglycemic Agents / pharmacology*
• Indoles
• Inositol / analogs & derivatives*
• Insulin / metabolism
• Insulin Resistance
• Insulin Secretion
• Isoindoles
• Nateglinide
• Phenylalanine / analogs & derivatives
• Risk Factors
• Stimulation, Chemical
• Sulfonylurea Compounds
• Thiazolidinediones